Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino)-3(2h)-pyridazinone Hydrochloride
2. Nm-702
3. Nt 702
4. Nt-702
5. Nt702 Cpd
6. Parogrelil Hydrochloride
1. 139145-27-0
2. Parogrelil [inn]
3. 2pcp9n33nh
4. 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-((pyridin-3-ylmethyl)amino)pyridazin-3(2h)-one
5. 5-bromo-3-[3-(4-chlorophenyl)propoxy]-4-(pyridin-3-ylmethylamino)-1h-pyridazin-6-one
6. Unii-2pcp9n33nh
7. Nt 702, Free Base
8. Mls006010243
9. Schembl149290
10. Dtxsid80930371
11. Bcpp000130
12. Bcp02174
13. Zinc1539352
14. Nt-702
15. Bcp9001051
16. Sb16958
17. Ncgc00346449-01
18. Ncgc00346449-02
19. 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(pyridin-3-ylmethylamino)pyridazin-3(2h)-one Hydrochloride (free Base)
20. Smr004701319
21. Ds-016806
22. 145p270
23. Q27255385
24. 4-bromo-5-(3-pyridylmethylamino)-6-(3-(4-chlorophenyl) Propoxy)-3-(2h)pyridazinone
25. 4-bromo-5-[(3-pyridyl)methylamino]-6-[3-(4-chlorophenyl)propoxy]pyridazine-3(2h)-one
26. 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-{[(pyridin-3-yl)methyl]amino}pyridazin-3-ol
27. 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(pyridin-3-ylmethylamino)pyridazin-3(2h)-one Hydrochloride (
28. 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(pyridin-3-ylmethyl)amino]-2,3-dihydropyridazin-3-one
| Molecular Weight | 449.7 g/mol |
|---|---|
| Molecular Formula | C19H18BrClN4O2 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 8 |
| Exact Mass | 448.03017 g/mol |
| Monoisotopic Mass | 448.03017 g/mol |
| Topological Polar Surface Area | 75.6 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 576 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Parogrelil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Parogrelil, including repackagers and relabelers. The FDA regulates Parogrelil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Parogrelil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Parogrelil supplier is an individual or a company that provides Parogrelil active pharmaceutical ingredient (API) or Parogrelil finished formulations upon request. The Parogrelil suppliers may include Parogrelil API manufacturers, exporters, distributors and traders.
click here to find a list of Parogrelil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Parogrelil DMF (Drug Master File) is a document detailing the whole manufacturing process of Parogrelil active pharmaceutical ingredient (API) in detail. Different forms of Parogrelil DMFs exist exist since differing nations have different regulations, such as Parogrelil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Parogrelil DMF submitted to regulatory agencies in the US is known as a USDMF. Parogrelil USDMF includes data on Parogrelil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Parogrelil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Parogrelil suppliers with USDMF on PharmaCompass.
Parogrelil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Parogrelil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Parogrelil GMP manufacturer or Parogrelil GMP API supplier for your needs.
A Parogrelil CoA (Certificate of Analysis) is a formal document that attests to Parogrelil's compliance with Parogrelil specifications and serves as a tool for batch-level quality control.
Parogrelil CoA mostly includes findings from lab analyses of a specific batch. For each Parogrelil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Parogrelil may be tested according to a variety of international standards, such as European Pharmacopoeia (Parogrelil EP), Parogrelil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Parogrelil USP).
LOOKING FOR A SUPPLIER?
